Synthesis, characterization, molecular docking studies and in vitro screening of new metal complexes with Schiff base as antimicrobial and antiproliferative agents
Abstract:A series of Cu(II), Co(II), Pd(II), Pt(II), Zn(II), Cd(II) and Fe(III) complexes were designed and synthesized using Schiff base 1‐phenyl‐2,3‐dimethyl‐4‐(N‐3‐formyl‐6‐methylchromone)‐3‐pyrazolin‐5‐one (HL). The new metal complexes were investigated using various physicochemical techniques including elemental and thermal analyses, molar electric conductivity and magnetic susceptibility measurements, as well as spectroscopic methods. Also, the crystal structures of ligand HL and the Pd(II) complex were determine… Show more
“…On the other hand, the best free binding energy between CHD and bacteria was found for E. faecalis (−11.24 kcal/mol), followed by S. sanguinis (−9.49 kcal/mol), and the highest value was found for S. mitis (−3.03 kcal/mol). Energy derived from the cobalt complex interaction with the L. paracasei structure was lower compared to the energy derived from CHD interaction with the same bacteria structure, suggesting that the complex couple is more stable, a fact observed for other metal complexes in the literature [41,42]. This observation is also in accordance with the antibacterial assay results which show a higher biological activity for [Co(atc-Ph) 2 ] + (MIC/MBC = 0.39/0.39 µg/mL) than for CHD (MIC/MBC = 0.92/0.92 µg/mL).…”
Section: Molecular Dockingmentioning
confidence: 72%
“…It is evident from the results obtained that both the [Co(atc-Ph) 2 ] + complex and CHD can successfully bind to one or more amino acids of all bacteria. The results of ∆G obtained were highly exothermic, which reveals good orientation and proximity, demonstrating the increment of the binding affinity [41]. The free binding energy between the [Co(atc-Ph) 2 ] + complex and bacteria was found to be −9.55 kcal/mol for L. paracasei, followed by −8.66 kcal/mol found for S. sanguinis.…”
Considering our previous findings on the remarkable activity exhibited by cobalt(III) with 2-acetylpyridine-N(4)-R-thiosemicarbazone (Hatc-R) compounds against Mycobacterium tuberculosis, the present study aimed to explored new structure features of the complexes of the type [Co(atc--R)2]Cl, where R = methyl (Me, 1) or phenyl (Ph, 2) (13C NMR, high-resolution mass spectrometry, LC–MS/MS, fragmentation study) together with its antibacterial and antiviral biological activities. The minimal inhibitory and minimal bactericidal concentrations (MIC and MBC) were determined, as well as the antiviral potential of the complexes on chikungunya virus (CHIKV) infection in vitro and cell viability. [Co(atc-Ph)2]Cl revealed promising MIC and MBC values which ranged from 0.39 to 0.78 µg/mL in two strains tested and presented high potential against CHIKV by reducing viral replication by up to 80%. The results showed that the biological activity is strongly influenced by the peripheral substituent groups at the N(4) position of the atc-R1− ligands. In addition, molecular docking analysis was performed. The relative binding energy of the docked compound with five bacteria strains was found in the range of −3.45 and −9.55 kcal/mol. Thus, this work highlights the good potential of cobalt(III) complexes and provide support for future studies on this molecule aiming at its antibacterial and antiviral therapeutic application.
“…On the other hand, the best free binding energy between CHD and bacteria was found for E. faecalis (−11.24 kcal/mol), followed by S. sanguinis (−9.49 kcal/mol), and the highest value was found for S. mitis (−3.03 kcal/mol). Energy derived from the cobalt complex interaction with the L. paracasei structure was lower compared to the energy derived from CHD interaction with the same bacteria structure, suggesting that the complex couple is more stable, a fact observed for other metal complexes in the literature [41,42]. This observation is also in accordance with the antibacterial assay results which show a higher biological activity for [Co(atc-Ph) 2 ] + (MIC/MBC = 0.39/0.39 µg/mL) than for CHD (MIC/MBC = 0.92/0.92 µg/mL).…”
Section: Molecular Dockingmentioning
confidence: 72%
“…It is evident from the results obtained that both the [Co(atc-Ph) 2 ] + complex and CHD can successfully bind to one or more amino acids of all bacteria. The results of ∆G obtained were highly exothermic, which reveals good orientation and proximity, demonstrating the increment of the binding affinity [41]. The free binding energy between the [Co(atc-Ph) 2 ] + complex and bacteria was found to be −9.55 kcal/mol for L. paracasei, followed by −8.66 kcal/mol found for S. sanguinis.…”
Considering our previous findings on the remarkable activity exhibited by cobalt(III) with 2-acetylpyridine-N(4)-R-thiosemicarbazone (Hatc-R) compounds against Mycobacterium tuberculosis, the present study aimed to explored new structure features of the complexes of the type [Co(atc--R)2]Cl, where R = methyl (Me, 1) or phenyl (Ph, 2) (13C NMR, high-resolution mass spectrometry, LC–MS/MS, fragmentation study) together with its antibacterial and antiviral biological activities. The minimal inhibitory and minimal bactericidal concentrations (MIC and MBC) were determined, as well as the antiviral potential of the complexes on chikungunya virus (CHIKV) infection in vitro and cell viability. [Co(atc-Ph)2]Cl revealed promising MIC and MBC values which ranged from 0.39 to 0.78 µg/mL in two strains tested and presented high potential against CHIKV by reducing viral replication by up to 80%. The results showed that the biological activity is strongly influenced by the peripheral substituent groups at the N(4) position of the atc-R1− ligands. In addition, molecular docking analysis was performed. The relative binding energy of the docked compound with five bacteria strains was found in the range of −3.45 and −9.55 kcal/mol. Thus, this work highlights the good potential of cobalt(III) complexes and provide support for future studies on this molecule aiming at its antibacterial and antiviral therapeutic application.
A bidentate NO donor Schiff base, 2-(((2-chloro-5-(trifluoromethyl)phenyl) imino)methyl) phenol (HL 1) and its complexes [Co(L 1) 2 (H 2 O) 2 ] (1), [Cu(L 1) 2 ] (2), [Mn(L 1) 2 (H 2 O) 2 ] (3), [Ni(L 1) 2 (H 2 O) 2 ] (4), [Pd 2 (L 1) 2 (OAc) 2 Á1.16H 2 O] (5), [Pt (L 1) 2 ] (6) were synthesized and characterized by different physico-chemical techniques including elemental and thermal analysis, magnetic susceptibility measurements, molar electric conductivity, IR, 1 H-NMR, 13 C-NMR, UV-Vis, mass spectroscopies and X-ray powder diffraction (XRD). The molecular structures of ligand HL 1 and two complexes (2 and 5) were confirmed by X-ray crystallography analysis on the monocrystal. In this complexes, the metal ions are in distorted square-planar environments. The copper (II) complex is mononuclear and crystallized in a monoclinic space group P21/c, whereas palladium (II) complex is dinuclear and crystallized in the trigonal crystal system R-3. The toxicity of the ligand and complexes was evaluated on both plant and animal cells, using the plant species Triticum aestivum L. and the crustacean Artemia franciscana Kellogg. At concentrations up to 100 μM the compounds presented very little toxicity on Artemia franciscana Kellogg. Moreover, the palladium (II) complex was devoid of any toxicity on the plant cells.
“…The abundance of electronic spectral bands within this complex also provided proof of the complex's trinuclearity. [19,70]. Based on these data, octahedral geometry was proposed for C5.…”
Section: Structural Characteristics Of the Compoundsmentioning
A major threat to public health worldwide is that the antimicrobial activity of the established drugs is constantly reduced due to the resistance that bacteria develop throughout the years. Some transition metal complexes show higher antibacterial activity against several bacteria compared to those of clinically used antibiotics. Novel classes of molecules provide new challenges and seem promising to solve the crisis that the overuse of antibiotics has led over the last years. This review discusses the challenges of chromium-based metallodrugs as antimicrobial agents. In particular, the synthetic routes, the structural characteristics, as well as the antimicrobial activity of 32 chromium (III) complexes have been presented.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.